NASDAQ: EDAP
Edap Tms Sa Stock Forecast, Predictions & Price Target

Analyst price target for EDAP

Based on 3 analysts offering 12 month price targets for Edap Tms Sa

Min Forecast
$2.00+38.89%
Avg Forecast
$8.50+490.28%
Max Forecast
$19.00+1,219.44%

Should I buy or sell EDAP stock?

Based on 3 analysts offering ratings for Edap Tms Sa.

Buy
Strong Buy
1 analysts 33.33%
Buy
1 analysts 33.33%
Hold
1 analysts 33.33%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their EDAP stock forecasts and price targets.

EDAP stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-04-04
lockedlocked$00.00+00.00%2025-03-28
lockedlocked$00.00+00.00%2025-03-28

1 of 1

Forecast return on equity

Is EDAP forecast to generate an efficient return?

Company
1.68%
Industry
433.51%
Market
81.87%
EDAP's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is EDAP forecast to generate an efficient return on assets?

Company
0.8%
Industry
7.05%
EDAP is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

EDAP earnings per share forecast

What is EDAP's earnings per share in the next 3 years based on estimates from 3 analysts?

Avg 1 year Forecast
-$0.61
Avg 2 year Forecast
-$0.51
Avg 3 year Forecast
-$0.34

EDAP revenue forecast

What is EDAP's revenue in the next 3 years based on estimates from 3 analysts?

Avg 1 year Forecast
$68.9M+3.2%
Avg 2 year Forecast
$69.2M+3.59%
Avg 3 year Forecast
$89.2M+33.5%
EDAP's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

EDAP revenue growth forecast

How is EDAP forecast to perform vs Medical Distribution companies and vs the US market?

Company
6.68%
Industry
7.91%
Market
10.37%
EDAP's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
EDAP's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

EDAP vs Medical Distribution Stocks

TickerPricePrice TargetUp/downsideConsensus
EDAP$1.44$8.50+490.28%Buy
ZYXI$2.13$10.25+381.22%Buy
SNYR$2.68$10.00+273.13%Strong Buy
COSM$0.32N/AN/A
AHG$1.07N/AN/A

Edap Tms Sa Stock Forecast FAQ

Is Edap Tms Sa Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 3 Wall Street analysts covering (NASDAQ: EDAP) stock is to Buy EDAP stock.

Out of 3 analysts, 1 (33.33%) are recommending EDAP as a Strong Buy, 1 (33.33%) are recommending EDAP as a Buy, 1 (33.33%) are recommending EDAP as a Hold, 0 (0%) are recommending EDAP as a Sell, and 0 (0%) are recommending EDAP as a Strong Sell.

If you're new to stock investing, here's how to buy Edap Tms Sa stock.

What is EDAP's earnings growth forecast for 2025-2027?

(NASDAQ: EDAP) Edap Tms Sa's forecast annual earnings growth rate of N/A is not forecast to beat the US Medical Distribution industry's average forecast earnings growth rate of 29.92%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 18.17%.

Edap Tms Sa's earnings in 2025 is -$20,671,739.On average, 3 Wall Street analysts forecast EDAP's earnings for 2025 to be -$22,673,588, with the lowest EDAP earnings forecast at -$25,039,235, and the highest EDAP earnings forecast at -$21,302,035. On average, 3 Wall Street analysts forecast EDAP's earnings for 2026 to be -$19,183,043, with the lowest EDAP earnings forecast at -$25,039,235, and the highest EDAP earnings forecast at -$16,069,957.

In 2027, EDAP is forecast to generate -$12,519,617 in earnings, with the lowest earnings forecast at -$17,938,556 and the highest earnings forecast at -$7,100,678.

What is EDAP's revenue growth forecast for 2025-2027?

(NASDAQ: EDAP) Edap Tms Sa's forecast annual revenue growth rate of 6.68% is not forecast to beat the US Medical Distribution industry's average forecast revenue growth rate of 7.91%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.37%.

Edap Tms Sa's revenue in 2025 is $69,689,130.On average, 3 Wall Street analysts forecast EDAP's revenue for 2025 to be $2,575,677,689, with the lowest EDAP revenue forecast at $2,339,486,699, and the highest EDAP revenue forecast at $2,949,023,889. On average, 3 Wall Street analysts forecast EDAP's revenue for 2026 to be $2,585,394,407, with the lowest EDAP revenue forecast at $2,180,282,013, and the highest EDAP revenue forecast at $3,307,421,292.

In 2027, EDAP is forecast to generate $3,332,086,807 in revenue, with the lowest revenue forecast at $2,376,858,691 and the highest revenue forecast at $4,287,314,922.

What is EDAP's forecast return on assets (ROA) for 2025-2028?

(NASDAQ: EDAP) forecast ROA is 0.8%, which is lower than the forecast US Medical Distribution industry average of 7.05%.

What is EDAP's Price Target?

According to 3 Wall Street analysts that have issued a 1 year EDAP price target, the average EDAP price target is $8.50, with the highest EDAP stock price forecast at $19.00 and the lowest EDAP stock price forecast at $2.00.

On average, Wall Street analysts predict that Edap Tms Sa's share price could reach $8.50 by Apr 4, 2026. The average Edap Tms Sa stock price prediction forecasts a potential upside of 490.28% from the current EDAP share price of $1.44.

What is EDAP's Earnings Per Share (EPS) forecast for 2025-2027?

(NASDAQ: EDAP) Edap Tms Sa's current Earnings Per Share (EPS) is -$0.55. On average, analysts forecast that EDAP's EPS will be -$0.61 for 2025, with the lowest EPS forecast at -$0.67, and the highest EPS forecast at -$0.57. On average, analysts forecast that EDAP's EPS will be -$0.51 for 2026, with the lowest EPS forecast at -$0.67, and the highest EPS forecast at -$0.43. In 2027, EDAP's EPS is forecast to hit -$0.34 (min: -$0.48, max: -$0.19).

What is EDAP's forecast return on equity (ROE) for 2025-2028?

(NASDAQ: EDAP) forecast ROE is 1.68%, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.